Clinical Trial Update: Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update showing safety and effectiveness results for PRX-08066 in patients with pulmonary hypertension and chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• PRX-08066

Snippet

Sponsor: Epix Pharmaceuticals, Inc. | Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED